Literature DB >> 9450996

A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.

K Newton1, A W Harris, M L Bath, K G Smith, A Strasser.   

Abstract

Members of the tumour necrosis factor receptor family that contain a death domain have pleiotropic activities. They induce apoptosis via interaction with intracellular FADD/MORT1 and trigger cell growth or differentiation via TRADD and TRAF molecules. The impact of FADD/MORT1-transduced signals on T lymphocyte development was investigated in transgenic mice expressing a dominant negative mutant protein, FADD-DN. Unexpectedly, FADD-DN enhanced negative selection of self-reactive thymic lymphocytes and inhibited T cell activation by increasing apoptosis. Thus signalling through FADD/MORT1 does not lead exclusively to cell death, but under certain circumstances can promote cell survival and proliferation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9450996      PMCID: PMC1170420          DOI: 10.1093/emboj/17.3.706

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  72 in total

1.  CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein.

Authors:  K V Prasad; Z Ao; Y Yoon; M X Wu; M Rizk; S Jacquot; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

2.  T-cell receptor ligation by peptide/MHC induces activation of a caspase in immature thymocytes: the molecular basis of negative selection.

Authors:  L K Clayton; Y Ghendler; E Mizoguchi; R J Patch; T D Ocain; K Orth; A K Bhan; V M Dixit; E L Reinherz
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

3.  Agonist antibody and Fas ligand mediate different sensitivity to death in the signaling pathways of Fas and cytoplasmic mutants.

Authors:  A R Thilenius; K Braun; J H Russell
Journal:  Eur J Immunol       Date:  1997-05       Impact factor: 5.532

4.  TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex.

Authors:  H Hsu; J Huang; H B Shu; V Baichwal; D V Goeddel
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  Target protease specificity of the viral serpin CrmA. Analysis of five caspases.

Authors:  Q Zhou; S Snipas; K Orth; M Muzio; V M Dixit; G S Salvesen
Journal:  J Biol Chem       Date:  1997-03-21       Impact factor: 5.157

Review 6.  Signal transduction by the neurotrophin receptors.

Authors:  D R Kaplan; F D Miller
Journal:  Curr Opin Cell Biol       Date:  1997-04       Impact factor: 8.382

7.  The receptor for the cytotoxic ligand TRAIL.

Authors:  G Pan; K O'Rourke; A M Chinnaiyan; R Gentz; R Ebner; J Ni; V M Dixit
Journal:  Science       Date:  1997-04-04       Impact factor: 47.728

8.  TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways.

Authors:  H Hsu; H B Shu; M G Pan; D V Goeddel
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

9.  Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice.

Authors:  R Amakawa; A Hakem; T M Kundig; T Matsuyama; J J Simard; E Timms; A Wakeham; H W Mittruecker; H Griesser; H Takimoto; R Schmits; A Shahinian; P Ohashi; J M Penninger; T W Mak
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

10.  Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis.

Authors:  A Strasser; A W Harris; D C Huang; P H Krammer; S Cory
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more
  105 in total

Review 1.  A portrait of the Bcl-2 protein family: life, death, and the whole picture.

Authors:  M Pellegrini; A Strasser
Journal:  J Clin Immunol       Date:  1999-11       Impact factor: 8.317

2.  Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

Authors:  D C Huang; M Hahne; M Schroeter; K Frei; A Fontana; A Villunger; K Newton; J Tschopp; A Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-21       Impact factor: 11.205

3.  MAPK/ERK signaling in activated T cells inhibits CD95/Fas-mediated apoptosis downstream of DISC assembly.

Authors:  T H Holmström; I Schmitz; T S Söderström; M Poukkula; V L Johnson; S C Chow; P H Krammer; J E Eriksson
Journal:  EMBO J       Date:  2000-10-16       Impact factor: 11.598

4.  Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism.

Authors:  J W Ramos; P E Hughes; M W Renshaw; M A Schwartz; E Formstecher; H Chneiweiss; M H Ginsberg
Journal:  Mol Biol Cell       Date:  2000-09       Impact factor: 4.138

5.  T cell-specific FADD-deficient mice: FADD is required for early T cell development.

Authors:  N H Kabra; C Kang; L C Hsing; J Zhang; A Winoto
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

6.  Transgenic expression of the coxsackie/adenovirus receptor enables adenoviral-mediated gene delivery in naive T cells.

Authors:  Y Y Wan; R P Leon; R Marks; C M Cham; J Schaack; T F Gajewski; J DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

7.  Shutdown of an acute T cell immune response to viral infection is mediated by the proapoptotic Bcl-2 homology 3-only protein Bim.

Authors:  Marc Pellegrini; Gabrielle Belz; Philippe Bouillet; Andreas Strasser
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

Review 8.  Death receptor signaling and autoimmunity.

Authors:  Richard M Siegel; Jagan Muppidi; Margaret Roberts; Melissa Porter; Zhengqi Wu
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 9.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

10.  Phosphorylated FADD induces NF-kappaB, perturbs cell cycle, and is associated with poor outcome in lung adenocarcinomas.

Authors:  Guoan Chen; Mahaveer S Bhojani; Andrew C Heaford; Daniel C Chang; Bharathi Laxman; Dafydd G Thomas; Laura B Griffin; James Yu; Julia M Coppola; Thomas J Giordano; Lin Lin; David Adams; Mark B Orringer; Brian D Ross; David G Beer; Alnawaz Rehemtulla
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.